These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3965374)

  • 81. [Steroid hormone receptor level in endometrial carcinoma].
    Bieglmayer C; Spona J; Ulm R; Husslein P
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():159-65. PubMed ID: 6242688
    [No Abstract]   [Full Text] [Related]  

  • 82. Failure of down-regulation of estrogen receptors and progesterone receptors after medroxyprogesterone acetate administration for endometrial hyperplasias.
    Masuzawa H; Badokhon NH; Nakayama K; Konishi I; Nikaido T; Fujii S
    Cancer; 1994 Oct; 74(8):2321-8. PubMed ID: 7922983
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Endolymphatic stromal myosis: report of a case treated surgically and with hormones.
    Jacobsen KB; Haram K
    Virchows Arch A Pathol Anat Histol; 1975 Dec; 369(2):173-9. PubMed ID: 814707
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
    Utaaker E; Iversen OE; Skaarland E
    Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Degree of manifestation of therapeutic pathomorphosis and the nature of the change in the estrogen and progesterone receptors after the radiation and chemotherapy of breast cancer].
    Ermilova VD; Koposova TL; Murav'ëva NI; Kuz'mina ZV
    Vopr Onkol; 1985; 31(12):69-73. PubMed ID: 4082510
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
    Creasman WT; Soper JT; McCarty KS; McCarty KS; Hinshaw W; Clarke-Pearson DL
    Am J Obstet Gynecol; 1985 Apr; 151(7):922-32. PubMed ID: 3985057
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Sex steroid receptors in gynecologic neoplasms.
    Carcangiu ML; Chambers JT
    Pathol Annu; 1992; 27 Pt 2():121-51. PubMed ID: 1584625
    [No Abstract]   [Full Text] [Related]  

  • 90. The status of receptors in the management of endometrial cancer.
    Richardson GS; MacLaughlin DT
    Clin Obstet Gynecol; 1986 Sep; 29(3):628-37. PubMed ID: 2944683
    [No Abstract]   [Full Text] [Related]  

  • 91. Hormonal therapy in endometrial carcinoma.
    Podratz KC
    Recent Results Cancer Res; 1990; 118():242-51. PubMed ID: 2236840
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Endolymphatic stromal myosis of the uterus with metastasis to ovary and recurrence in vagina.
    Yu TJ; Iwasaki I; Horie H; Tamaru J; Takahashi A
    Acta Pathol Jpn; 1986 Feb; 36(2):301-8. PubMed ID: 3705963
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hormonal treatment of endometrial carcinoma: an overview and new development in biology.
    Satyaswaroop PG; Mortel R
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):997-1001. PubMed ID: 2285611
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Endolymphatic stromal myosis (endometrial low-grade stromal sarcoma) presenting with hematuria: a diagnostic challenge.
    Dgani R; Shoham Z; Czernobilsky B; Singer D; Shani A; Lancet M
    Gynecol Oncol; 1989 Nov; 35(2):263-6. PubMed ID: 2807022
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Metastatic endometrial cancer in lung and liver: complete and prolonged response to hormonal therapy with progestins.
    Crespo C; González-Martín A; Lastra E; García-López J; Moyano A
    Gynecol Oncol; 1999 Feb; 72(2):250-5. PubMed ID: 10021310
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Progestinic treatment of mastodynia. New suggestion for the follow-up.
    Onnis A; Nardelli GB; Mozzanega B; Lamaina V; Onnis GL; Maggino T; Litta P; Marchetti M
    Eur J Gynaecol Oncol; 1984; 5(1):11-5. PubMed ID: 6698048
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Progestational therapy and metastatic adenocarcinoma of the body of the uterus.
    Mackay EV
    Med J Aust; 1969 Feb; 1(5):230-1. PubMed ID: 5781642
    [No Abstract]   [Full Text] [Related]  

  • 98. Effect of progesterone on metastases and local recurrences of carcinoma of the uterine corpus.
    Karlstedt K
    Acta Obstet Gynecol Scand Suppl; 1972; 19():11-2. PubMed ID: 4508280
    [No Abstract]   [Full Text] [Related]  

  • 99. Progesterone treatment for local recurrence and metastases in carcinoma corporis uteri.
    Karlstedt K
    Acta Radiol Ther Phys Biol; 1971 Apr; 10(2):187-92. PubMed ID: 5556820
    [No Abstract]   [Full Text] [Related]  

  • 100. Pulmonary lymphangiomyomatosis responsive to progesterone.
    McCarty KS; Mossler JA; McLelland R; Sieker HO
    N Engl J Med; 1980 Dec; 303(25):1461-5. PubMed ID: 7432404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.